Neonakis I K, Gitti Z, Kontos F, Baritaki S, Petinaki E, Baritaki M, Liakou V, Zerva L, Spandidos D A
Mycobacteriology Laboratory, Department of Clinical Bacteriology, Parasitology, Zoonoses and Geographical Medicine, University Hospital of Heraklion, Heraklion, Greece.
Indian J Med Microbiol. 2010 Apr-Jun;28(2):173-6. doi: 10.4103/0255-0857.62502.
Mycobacterium arupense is a novel mycobacterium species. It was first identified from clinical specimens in 2006 and since then there have been only two reports of its recovery from clinical samples. In the present case M. arupense was isolated from the sputum of a 62-year-old man with a malignant mass in his left kidney, who presented with a one-month history of recurrent fever, dyspnea and haemoptysis. M. arupense was identified with sequencing of hsp65 and 16S rRNA genes. In the present study, its biochemical profile along with its resistance status and hsp65 RFLP analysis is presented.
阿鲁彭斯分枝杆菌是一种新型分枝杆菌。它于2006年首次从临床标本中鉴定出来，自那时起，仅有两份关于从临床样本中分离出该菌的报告。在本病例中，阿鲁彭斯分枝杆菌是从一名62岁左肾有恶性肿块的男性患者的痰液中分离出来的，该患者有1个月反复发热、呼吸困难和咯血的病史。通过hsp65和16S rRNA基因测序鉴定出阿鲁彭斯分枝杆菌。在本研究中，呈现了其生化特征、耐药状况以及hsp65限制性片段长度多态性分析结果。
